For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Kobiolabs, Inc.

USPTO Granted Patents = 13

EPO Patents = 1

Trademarks = 2

Forward Citations = 3

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Gwang Pyo Ko (10 out of 10 patents)

Tae-Wook Nam (5 out of 5 patents)

Hyun Ju You (5 out of 5 patents)

4. Boram Seo (4 out of 4 patents)

5. Woo Ri Ko (4 out of 4 patents)

6. June Chul Lee (4 out of 6 patents)

7. Woon Ki Kim (4 out of 4 patents)

8. GwangPyo Ko (3 out of 4 patents)

9. Tae Wook Nam (3 out of 4 patents)

10. Jin-Woo Lee (2 out of 65 patents)

11. Woonki Kim (2 out of 2 patents)

12. You-Jin Jang (2 out of 2 patents)

13. June-Chul Lee (2 out of 2 patents)

14. Insu Kim (2 out of 2 patents)

15. Dae Hee Han (2 out of 5 patents)

13 patents: Sort by Forward Citations

1. 12441979 - strain and use thereof (2025-10-14),

2. 12274718 - Composition and method for preventing, alleviating, or treating liver injury (2025-04-14),

3. 12070477 - sp. strain having ability to inhibit growth of vaginal pathogenic microorganisms (2024-08-27),

4. 11992511 - strain and use thereof (2024-05-28),

5. 11903980 - Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community (2024-02-20),

6. 11819526 - Lactobacillus Gasseri KBL697 strain and use thereof (2023-11-21),

7. 11633439 - Lactobacillus crispatus KBL693 strain and use thereof (2023-04-25),

8. 11602552 - Lactobacillus plantarum KBL396 strain and use thereof (2023-03-14),

9. 11510948 - Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community (2022-11-29),

10. 11365452 - Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiome (2022-06-21),

11. 11291698 - strain and use thereof (2022-04-05),

12. 11285183 - KBL697 strain and use thereof (2022-03-29),

13. 11141444 - KBL693 strain and use thereof (2021-10-12),

Kobiolabs, Inc. is a technology company that specializes in developing innovative solutions for the healthcare industry. With a focus on digital health and telemedicine, Kobiolabs aims to revolutionize the way healthcare is delivered and accessed. Their cutting-edge products and services help healthcare providers improve patient outcomes and streamline their operations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

13 Patents

#315 in Seoul

#876 in South Korea

#44,906 in the World

Seoul, South Korea

Kobiolabs, Inc.

Forward Citations = 3

35 inventors:

Gwang Pyo Ko (10 out of 10 patents)

Tae-Wook Nam (5 out of 5 patents)

Hyun Ju You (5 out of 5 patents)

4. Boram Seo (4 out of 4 patents)

5. Woo Ri Ko (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…